1.
|
International Agency for Research on
Cancer, World Health Organization. Globocan 2008. World Health
Organization Web site. http://globocan.iarc.fr/uri.
Accessed October 1, 2010.
|
2.
|
Ishii H, Furuse J, Boku N, et al: Phase II
study of gemcitabine chemotherapy alone for locally advanced
pancreatic carcinoma: JCOG0506. Jpn J Clin Oncol. 40:573–579. 2010.
View Article : Google Scholar : PubMed/NCBI
|
3.
|
Evans DB, Abbruzzese JL and Willett CG:
Cancer of the pancreas. Cancer: Priciples and Practice of Oncology.
6th edition. De Vita, Hellman S and Rosenberg SA: Lippincott,
Williams and Wilkins; Philadelphia: pp. 1126–1161. 2001
|
4.
|
Oettle H, Post S, Neuhaus P, et al:
Adjuvant chemotherapy with gemcitabine vs. observation in patients
undergoing curative-intent resection of pancreatic cancer: a
randomized controlled trial. JAMA. 297:267–277. 2007. View Article : Google Scholar
|
5.
|
Aloia TE, Lee JE, Vauthey JN, et al:
Delayed recovery after pancreaticoduodenectomy: a major factor
impairing the delivery of adjuvant chemotherapy? J Am Coll Surg.
204:347–355. 2007. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Sandy H, Bruckner H, Cooperman A, Paradiso
J and Kiefer L: Survival advantage of combined chemoradiotherapy
compared with resection as the initial treatment of patients with
regional pancreatic carcinoma. An outcomes trial Cancer.
89:314–327. 2000.
|
7.
|
Ensminger WD, Rosowsky A and Raso V: A
clinical pharmacological evaluation of hepatic arterial infusions
of 5-fluoro-2-deoxyuridine and 5-fluorourcil. Cancer Res.
38:3784–3792. 1978.PubMed/NCBI
|
8.
|
Vogl TJ, Schwarz W, Eichler K, et al:
Hepatic intraarterial chemotherapy with gemcitabine in patients
witn unresectable cholangiocarcinoma and liver metastases of
pancreatic cancer: a clinical study on maximum tolerable dose and
treatment efficacy. J Cancer Res Clin Oncol. 132:745–755. 2006.
View Article : Google Scholar
|
9.
|
Tse AN, Wu N, Patel D, Haviland D and
Kemeny N: A phase I study of gemcitabine given via intrahepatic
pump for primary or metastatic hepatic malignancies. Cancer
Chemother Pharmacol. 64:935–944. 2009. View Article : Google Scholar : PubMed/NCBI
|
10.
|
Van Riel JM, Peters GJ, Mammatas LH, et
al: A phase I and pharmacokinetic study of gemcitabine given by
24-h hepatic arterial infusion. Eur J Cancer. 45:2519–2527.
2009.PubMed/NCBI
|
11.
|
Tajima H, Ohta T, Kitagawa H, et al:
Hepatic arterial infusion chemotherapy for post-operative liver
metastases from pancreatic cancer in a patient with leukocytopenia:
a case report. Exp Therap Med. 1:987–990. 2010.PubMed/NCBI
|
12.
|
Urata K, Kawasaki S, Matsunami T, et al:
Calculation of child and adult standard liver volume for liver
transplantation. Hepatology. 21:1317–1321. 1995.PubMed/NCBI
|
13.
|
Therasse P, Arbuck SG, Eisenhauer EA, et
al: New guidelines to evaluate the response to treatment in solid
tumors. European Organization for Research and Treatment of Cancer,
National Cancer Institute of the United States National Cancer
Institute of Canada. J Natl Cancer Inst. 92:205–216. 2000.
View Article : Google Scholar
|
14.
|
Nagakawa T, Nagamori M, Futakami F, et al:
Result of extensive surgery for pancreatic carcinoma. Cancer.
77:640–645. 1996. View Article : Google Scholar : PubMed/NCBI
|
15.
|
Noto M, Miwa K, Kitagawa H, et al:
Pancreas head carcinoma. Frequency of invasion to soft tissue
adherent to the superior mesenteric artery. Am J Surg Pathol.
29:1056–1061. 2005.PubMed/NCBI
|
16.
|
Spitz FR, Abbruzzese JL, Lee JE, et al:
Preoperative and postoperative chemoradiation strategies in
patients treated with pancreaticoduodenectomy for adenocarcinoma of
the pancreas. J Clin Oncol. 15:928–937. 1997.PubMed/NCBI
|
17.
|
Hoffman JP, Lipsitz S, Pisansky T, Weese
JL, Solin L and Benson AB: Phase II trial of preoperative radiation
therapy and chemotherapy for patients with localized, resectable
adenocarcinoma of the pancreas: an Eastern Cooperative Oncology
Group Study. J Clin Oncol. 16:317–323. 1998.
|
18.
|
Palmer DH, Stocken DD, Hewitt H, et al: A
randomized phase 2 trial of neoadjuvant chemotherapy in resectable
pancreatic cancer: gemicitabine alone versus gemcitabine combined
with cisplatin. Ann Surg Oncol. 14:2088–2096. 2007. View Article : Google Scholar
|
19.
|
Golcher H, Brunner T, Grabenbauer G, et
al: Preoperative chemoradiation in adenocarcinoma of the pancreas.
A single centre experience advocating a new treatment strategy. Eur
J Surg Oncol. 34:756–764. 2008. View Article : Google Scholar : PubMed/NCBI
|
20.
|
Turrini O, Viret F, Zabotto LM, et al:
Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on
survival in patients with resectable pancreatic head
adenocarcinoma: a ten-year single institution experience. Oncology.
76:413–419. 2009.
|
21.
|
Takai S, Satoi S, Yanagimoto H, et al:
Neoadjuvant chemoradiation in patients with potentially resectable
pancreatic cancer. Pancreas. 36:26–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
22.
|
Satoi S, Yanaagimoto H, Toyokawa H, et al:
Surgical results after prepoerative chemoradiation therapy for
patients with pancreatic cancer. Pancreas. 38:282–288. 2009.
View Article : Google Scholar : PubMed/NCBI
|
23.
|
Cohen AD and Kemeny NE: An update on
hepatic arterial infusion chemotherapy for colorectal cancer.
Oncologist. 8:553–566. 2003. View Article : Google Scholar : PubMed/NCBI
|
24.
|
Mocellin S, Pilati P, Lise M and Nitti D:
Meta-analysis of hepatic arterial infusion for unresectable liver
metastases from colorectal cancer: the end of an era? J Clin Oncol.
25:5649–5654. 2007. View Article : Google Scholar : PubMed/NCBI
|
25.
|
Homma H, Akiyama T, Mezawa S, et al:
Advanced pancreatic carcinoma showing a complete response to
arterial infusion chemotherapy. Int J Clin Oncol. 9:197–201. 2004.
View Article : Google Scholar : PubMed/NCBI
|
26.
|
Miyanishi K, Ishiwatari H and Hayashi T: A
phase I trial of arterial infusion chemotherapy with gemcitabine
and 5-fluorouracil for unresectable advanced pancreatic cancer
after vascular supply distribution via superselective embolization.
Jpn J Clin Oncol. 38:268–274. 2008. View Article : Google Scholar
|
27.
|
Mogami K, Ichihara T, Sato T, et al: A
case of the papilla of vater accompanied witn a stricture of the
celiac artery by the median arcuate ligament. Jpn J Gastroenterol
Surg. 41:1588–1593. 2008. View Article : Google Scholar
|
28.
|
Kikuchi K and Kanno H: Comparison for
blood levels and clinical effects between tablet and other dosage
forms of 5-fluorouracil (5-FU). Gan To Kagaku Ryouho. 6:559–565.
1979.
|
29.
|
Maruyama S, Ando M and Watayo T:
Concentration of 5-FU after hepatic artery infusion chemotherapy
for liver metastases of colorectal cancer. Gan To Kagaku Ryouho.
30:1635–1638. 2003.PubMed/NCBI
|